These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36453810)

  • 21. Adhering to the procalcitonin algorithm allows antibiotic therapy to be shortened in patients with ventilator-associated pneumonia.
    Beye F; Vigneron C; Dargent A; Prin S; Andreu P; Large A; Quenot JP; Bador J; Bruyere R; Charles PE
    J Crit Care; 2019 Oct; 53():125-131. PubMed ID: 31228763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
    van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
    Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procalcitonin-Guided Antibiotic Therapy Reduces Antibiotic Use for Lower Respiratory Tract Infections in a United States Medical Center: Results of a Clinical Trial.
    Townsend J; Adams V; Galiatsatos P; Pearse D; Pantle H; Masterson M; Kisuule F; Jacob E; Kiruthi C; Ortiz P; Agbanlog A; Jurao R; Stern S; Nayak S; Melgar M; Sama J; Irwin J; Mazidi C; Psoter K; McKenzie R
    Open Forum Infect Dis; 2018 Dec; 5(12):ofy327. PubMed ID: 30619913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
    Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
    Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial.
    Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM
    J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis.
    Prkno A; Wacker C; Brunkhorst FM; Schlattmann P
    Crit Care; 2013 Dec; 17(6):R291. PubMed ID: 24330744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock.
    Hohn A; Schroeder S; Gehrt A; Bernhardt K; Bein B; Wegscheider K; Hochreiter M
    BMC Infect Dis; 2013 Apr; 13():158. PubMed ID: 23547790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach.
    Fantoni M; Taddei E; Cauda R; Antonelli Incalzi R; Capone A; Cortese F; Sanguinetti M; Spandonaro F; Urbani A; Murri R
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2978-2985. PubMed ID: 31002168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The budget impact of procalcitonin-guided antibiotic stewardship compared to standard of care for patients with suspected sepsis admitted to the intensive care unit in Belgium.
    Garnfeldt VM; Vincent JL; Gruson D; Garay OU; Vansieleghem S; Iniguez L; Lefevre A
    PLoS One; 2023; 18(10):e0293544. PubMed ID: 37903106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.
    Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K
    Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of procalcitonin-guided antibiotic therapy to shorten treatment duration in critically-ill patients with bloodstream infections: a systematic review and meta-analysis.
    Robati Anaraki M; Nouri-Vaskeh M; Abdoli Oskouie S
    Infez Med; 2020 Mar; 28(1):37-46. PubMed ID: 32172259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
    Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ
    Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963
    [No Abstract]   [Full Text] [Related]  

  • 36. Compliance with Procalcitonin Algorithm Antibiotic Recommendations for Patients in Medical Intensive Care Unit.
    Ammar AA; Lam SW; Duggal A; Neuner EA; Bass SN; Guzman JA; Wang XF; Han X; Bauer SR
    Pharmacotherapy; 2017 Feb; 37(2):177-186. PubMed ID: 27997675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procalcitonin utilization in the real world: An observational study of antibiotic prescribing practices.
    Choi JJ; Cornelius-Schecter A; Hayden JA; Jannat-Khah DP; O'Connell A; Baduashvili A; Lee J; McCarthy MW
    J Eval Clin Pract; 2020 Aug; 26(4):1220-1223. PubMed ID: 31667954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Procalcitonin to reduce exposure to antibiotics and individualise treatment in hospitalised old patients with pneumonia: a randomised study.
    Gavazzi G; Drevet S; Debray M; Bosson JL; Tidadini F; Paccalin M; de Wazieres B; Celarier T; Bonnefoy M; Vitrat V
    BMC Geriatr; 2022 Dec; 22(1):965. PubMed ID: 36517740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19.
    Wolfisberg S; Gregoriano C; Schuetz P
    Crit Rev Clin Lab Sci; 2022 Jan; 59(1):54-65. PubMed ID: 34517744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
    So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
    Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.